van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an essic proposal. Eur Urol. 2008;53:60–7.

Article  PubMed  Google Scholar 

Cox A, Golda N, Nadeau G, Nickel JC, Carr L, Corcos J, Teichman J. CUA guideline: diagnosis and treatment of interstitial cystitis/ bladder pain syndrome. Can Urol Assoc J. 2016;10:136–55.

Article  Google Scholar 

Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208:34–42.

Article  PubMed  Google Scholar 

Hanno P, Cervigni M, Choo MS, Clemens JQ, Lee M-H, Malde S, Meijlink J, Samarinas M, Ueda T, Gold D. Summary of the 2023 report of the international consultation on incontinence interstitial cystitis/bladder pain syndrome (IC/BPS) committee. Continence. 2023;8:101056.

Article  Google Scholar 

European Association of Urology (EAU) guidelines. Available from: https://uroweb.org/guidelines. Accessed 14 Sept 2024.

Homma Y, Akiyama Y, Kim JH, et al. Definition change and update of clinical guidelines for interstitial cystitis and bladder pain syndrome. LUTS: Low Urin Tract Symptoms. 2024;16:e12532.

Article  PubMed  CAS  Google Scholar 

Nickel JC, Mills IW, Crook TJ, Jorga A, Smith MD, Atkinson G, Krieger JN. Tanezumab reduces pain in women with interstitial cystitis/bladder pain syndrome and patients with nonurological associated somatic syndromes. J Urol. 2016;195:942–8.

Article  PubMed  CAS  Google Scholar 

Nickel JC, Crossland A, Davis E, Haab F, Mills IW, Rovner E, Scholfield D, Crook T. Investigation of a Ca2+ Channel α2δ ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase ii trial. J Urol. 2012;188:817–23.

Article  PubMed  CAS  Google Scholar 

Yang CC, Burks DA, Propert KJ, et al. Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned. J Urol. 2011;185:901–6.

Article  PubMed  PubMed Central  Google Scholar 

Evans R, Kohan A, Moldwin R, Radecki D, Geib T, Peters KM. Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions. Neurourol Urodyn. 2021;40:1730–9.

Article  PubMed  CAS  Google Scholar 

Nickel JC, Moldwin R, Hanno P, Dmochowski R, Peters KM, Payne C, Wein A. Targeting the SHIP1 pathway fails to show treatment benefit in interstitial cystitis/bladder pain syndrome: lessons learned from evaluating potentially effective therapies in this enigmatic syndrome. J Urol. 2019;202:301–8.

Article  PubMed  Google Scholar 

Farrar J, Locke K, Clemens J, et al. Widespread pain phenotypes impact treatment efficacy results in randomized clinical trials for interstitial cystitis/ bladder pain syndrome: A MAPP Network Study. Pain. 2024. https://doi.org/10.1097/j.pain.0000000000003455.

Article  PubMed  PubMed Central  Google Scholar 

Shoskes DA, Nickel JC, Dolinga R, Prots D. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology. 2009;73:538–42.

Article  PubMed  Google Scholar 

Crane A, Lloyd J, Shoskes DA. Improving the utility of clinical phenotyping in interstitial cystitis/painful bladder syndrome: from UPOINT to INPUT. Can J Urol. 2018;25:9250–4.

PubMed  Google Scholar 

Lai HH, Pickersgill NA, Vetter JM. Hunner Lesion phenotype in interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis. J Urol. 2020;204:518–23.

Article  PubMed  Google Scholar 

Gupta P, Gallop R, Spitznagle T, et al. Is pelvic floor muscle tenderness a distinct urologic chronic pelvic pain syndrome phenotype? findings from the multidisciplinary approach to the study of chronic pelvic pain research network symptom pattern study. J Urol. 2022;208:341–9.

Article  PubMed  PubMed Central  Google Scholar 

Lai HH, Jemielita T, Sutcliffe S, et al. Characterization of whole body pain in urological chronic pelvic pain syndrome at baseline: a mapp research network study. J Urol. 2017;198:622–31.

Article  PubMed  PubMed Central  Google Scholar 

Brown VL, James A, Hunleth J, et al. Believing women: a qualitative exploration of provider disbelief and pain dismissal among women with interstitial cystitis/bladder pain syndrome from the MAPP research network. Int Urogynecology J. 2024;35:139–48.

Article  Google Scholar 

McKernan LC, Walsh CG, Reynolds WS, Crofford LJ, Dmochowski RR, Williams DA. Psychosocial co-morbidities in Interstitial Cystitis/Bladder Pain syndrome (IC/BPS): A systematic review. Neurourol Urodyn. 2018;37:926–41.

Article  PubMed  Google Scholar 

Lackner JM, Clemens JQ, Radziwon C, et al. Cognitive behavioral therapy for chronic pelvic pain: what is it and does it work? J Urol. 2024;211:539–50.

Article  PubMed  Google Scholar 

McKernan LC, Bonnet KR, Finn MTM, Williams DA, Bruehl S, Reynolds WS, Clauw D, Dmochowski RR, Schlundt DG, Crofford LJ. Qualitative analysis of treatment needs in interstitial cystitis/bladder pain syndrome: Implications for intervention. Can J Pain. 2020;4:181–98.

Article  PubMed  PubMed Central  Google Scholar 

Olson LE, Dyer JE, Haq A, Ockrim J, Greenwell TJ. A systematic review of the literature on cystodistension in bladder pain syndrome. Int Urogynecology J. 2018;29:251–7.

Article  Google Scholar 

Rahnama’i MS, Marand AJB, Janssen D, Mostafaei H, Gatsos S, Hajebrahimi S, Apostolidis A, Taneja R. Botulinum toxin therapy for bladder pain syndrome/interstitial cystitis. Curr Bl Dysfunct Rep. 2023;18:147–53.

Article  Google Scholar 

Zargham M, Mahmoodi M, Mazdak H, Tadayon F, Mansori M, Kazemi M, Khorami MH, Saberi N. Evaluation of therapeutic effect of intratrigonal injection of abobotulinumtoxina(dysport) and hydrodistention in refractory interstitial cystitis /bladder pain syndrome. Urol J. 2022;18:5879–5879.

Google Scholar 

Dobberfuhl AD, van Uem S, Versi E. Trigone as a diagnostic and therapeutic target for bladder-centric interstitial cystitis/bladder pain syndrome. Int Urogynecology J. 2021;32:3105–11.

Article  Google Scholar 

Jones P, Hjelle KM, Mohn J, Guðbrandsdottir G, Roth I, Chaudhry AA, Bergesen AK, Beisland C. Current status of intravesical therapies for Bladder Pain Syndrome (BPS): a narrative review of emerging evidence. Urology. 2021;156:e48–57.

Article  PubMed  Google Scholar 

Nickel JC, Barkin J, Forrest J, et al. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology. 2005;65:654–8.

Article  PubMed  Google Scholar 

Nickel JC, Herschorn S, Whitmore KE, Forrest JB, Hu P, Friedman AJ, Baseman AS. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J Urol. 2015;193:857–62.

Article  PubMed  CAS  Google Scholar 

Su M (2015) Amitriptyline Therapy in Chronic Pain. Int Arch Clin Pharmacol. https://doi.org/10.23937/2572-3987.1510001

dos Pereira CS, Cruz JN, Ferreira MKM, Baia-da-Silva DC, Fontes-Junior EA, Lima RR. Global research trends and hotspots analysis of the scientific production of amitriptyline: a bibliometric approach. Pharmaceuticals. 2023;16:1047.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ma Y, Kang Z, Shi Y, Ji W, Zhou W, Nan W. The complexity of neuropathic pain and central sensitization: exploring mechanisms and therapeutic prospects. J Integr Neurosci. 2024;23:89.

Article  PubMed  Google Scholar 

FitzGerald MP, Anderson RU, Potts J, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2013;189:S75–85.

Article  PubMed  PubMed Central  Google Scholar 

van Reijn-Baggen DA, Han-Geurts IJM, der Zalm PJV, Pelger RCM, Miert CHACH, Laan ETM. Pelvic floor physical therapy for pelvic floor hypertonicity: a systematic review of treatment efficacy. Sex Med Rev. 2022;10:209–30.

Article  PubMed  Google Scholar 

Lam C, Francio VT, Gustafson K, Carroll M, York A, Chadwick AL. Myofascial pain – A major player in musculoskeletal pain. Best Pr Res Clin Rheumatol. 2024;38:101944.

Article  Google Scholar 

Stone RH, Abousaud M, Abousaud A, Kobak W. A systematic review of intravaginal diazepam for the treatment of pelvic floor hypertonic disorder. J Clin Pharmacol. 2020;60:S110–20.

Article  PubMed  CAS  Google Scholar